Our mission is to ensure the generation of accurate and precise findings.
Please enter subscribe form shortcode
Please enter instagram feed shortcode
What if the biggest risk to your First-Patient-In (FPI) date isn’t the recruitment site, but the kit design? In my 25+ years in pharmaceutical supply chain, I’ve watched many Clinical Trial Managers (CTMs) navigate the grueling path of protocol design and site selection, only to be blindsided by “the box.” While your focus is rightfully […]
If your clinical supply process is inconsistent, undocumented, or dependent on heroics, what exactly do you expect AI to optimize? There’s a growing belief that layering AI on top of operational chaos will magically create efficiency. But in clinical supply, where patient safety, expiry management, and global coordination hinge on precision, AI doesn’t fix […]
What if the biggest risk in your clinical supply chain isn’t forecasting, recruitment volatility, or vendor performance — but the silent erosion of data integrity every time information changes hands? We talk endlessly about systems, platforms, and digital transformation. Yet the real cracks often appear in the mundane moments: a spreadsheet emailed instead of uploaded, […]
The clinical supply chain has evolved from an operational function into a strategic enabler of trial readiness, regulatory success, and patient impact. As therapies advance and global trials expand, leadership—not management—defines the difference between execution and sustained excellence. This article highlights the leadership capabilities that elevate performance across communication, team development, change management, executive reporting, […]
December 30, 2025 Clinical supply chain leaders are entering 2026 with a new mandate: control costs without compromising flexibility, quality, or patient access. The pressure is real—and the organizations that get this right will accelerate development while everyone else fights fires. Here’s what’s driving the urgency: 🔹 Rising manufacturing & packaging costs Energy, […]
Clinical Supply Chains Are Entering Their “AI‑Native” Era — And 2026 Is the Breakout Year For decades, clinical supply has been treated as a back‑office function. In 2026, it’s becoming a strategic engine — one that accelerates development timelines, reduces cost, and expands global patient access. The catalyst? AI is no longer an experiment. It’s the new […]
https://www.linkedin.com/in/jgoberlander/?lipi=urn%3Ali%3Apage%3Ad_flagship3_pulse_read%3B6xTGMp88S8yrUkVanKmQOw%3D%3D Joseph G. Oberlander, Ph.D., PMP Program Manager ♦ Neuroscientist ♦ Author Clinical trials are the backbone of medical innovation, but their supply chains have traditionally been complex, fragmented, and vulnerable to disruption. From ensuring investigational drugs reach patients on time to managing global logistics, the stakes are high. Artificial Intelligence (AI) is now emerging […]
As 2025 closes, several December analyses across healthcare and supply chain publications point to the same conclusion: clinical supply chains are entering 2026 with higher volatility, tighter capacity, and increasing regulatory scrutiny — but also unprecedented opportunities for digital acceleration. A few patterns stand out: 1. Non‑labor cost pressure is now a structural reality, not […]
